

Transforming immune discovery through AI and function-first biology.
ABOUT
Feromics is an immunomics company leveraging AI and function-first single-cell immune profiling to engineer next-generation immunotherapies and transform how responses are predicted.

TECHNOLOGY
At Feromics, we generate large-scale single-cell functional immunomics datasets using our proprietary platforms, which directly link real-time immune cell behavior to molecular state. These uniquely annotated datasets power our internally trained AI and deep-learning models to uncover therapeutically actionable immune pathways and predictive biomarkers. Our integrated technology platform supports the development and optimization of next-generation immunotherapies, including immune engagers, CAR-T, and allogeneic cell therapies, while enabling donor selection, patient stratification, and prediction of therapeutic response.
The Feromics Advantage
FASTER TRAINING
The AI scales clean functional signal from the start, rather than searching for meaning in a mixture of signal and noise.
LOWER COST
Functional immunomics data requires fewer samples, less compute time, and fewer experimental iterations to produce high-confidence results.
MORE RELIABLE OUTPUT
The data is built around function and disease specificity from the start, so discoveries returned by the model are grounded in biology already validated before the AI began.
